Sen. Wyden Continues Investigation Into Big Pharma Tax Practices
January 19, 2022
January 19, 2022
WASHINGTON, Jan. 19 -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following news release on Jan. 18, 2022:
Senate Finance Committee Chair Ron Wyden, D-Ore., today continued his investigation into Big Pharma's tax practices, and how loopholes in the tax code have allowed multinational companies to further abuse tax havens and avoid paying U.S. taxes on prescription drug sales. Wyden wrote to Bristol Myers Squibb to request information about their r . . .
Senate Finance Committee Chair Ron Wyden, D-Ore., today continued his investigation into Big Pharma's tax practices, and how loopholes in the tax code have allowed multinational companies to further abuse tax havens and avoid paying U.S. taxes on prescription drug sales. Wyden wrote to Bristol Myers Squibb to request information about their r . . .